Literature DB >> 8264635

An epidermal growth factor receptor/ret chimera generates mitogenic and transforming signals: evidence for a ret-specific signaling pathway.

M Santoro1, W T Wong, P Aroca, E Santos, B Matoskova, M Grieco, A Fusco, P P di Fiore.   

Abstract

A chimeric expression vector which encoded for a molecule encompassing the extracellular domain of the epidermal growth factor (EGF) receptor (EGFR) and the intracellular domain of the ret kinase (EGFR/ret chimera) was generated. Upon ectopic expression in mammalian cells, the EGFR/ret chimera was correctly synthesized and transported to the cell surface, where it was shown capable of binding EGF and transducing an EGF-dependent signal intracellularly. Thus, the EGFR/ret chimera allows us to study the biological effects and biochemical activities of the ret kinase under controlled conditions of activation. Comparative analysis of the growth-promoting activity of the EGFR/ret chimera expressed in fibroblastic or hematopoietic cells revealed a biological phenotype clearly distinguishable from that of the EGFR, indicating that the two kinases couple with mitogenic pathways which are different to some extent. Analysis of biochemical pathways implicated in the transduction of mitogenic signals also evidenced significant differences between the ret kinase and other receptor tyrosine kinases. Thus, the sum of our results indicates the existence of a ret-specific pathway of mitogenic signaling.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8264635      PMCID: PMC358416          DOI: 10.1128/mcb.14.1.663-675.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  79 in total

1.  The erbB-2 mitogenic signaling pathway: tyrosine phosphorylation of phospholipase C-gamma and GTPase-activating protein does not correlate with erbB-2 mitogenic potency.

Authors:  F Fazioli; U H Kim; S G Rhee; C J Molloy; O Segatto; P P Di Fiore
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

Review 2.  Recent insights in phosphatidylinositol signaling.

Authors:  P W Majerus; T S Ross; T W Cunningham; K K Caldwell; A B Jefferson; V S Bansal
Journal:  Cell       Date:  1990-11-02       Impact factor: 41.582

3.  Specific expression of the ret proto-oncogene in human neuroblastoma cell lines.

Authors:  I Ikeda; Y Ishizaka; T Tahira; T Suzuki; M Onda; T Sugimura; M Nagao
Journal:  Oncogene       Date:  1990-09       Impact factor: 9.867

4.  Protein-tyrosine kinases regulate the phosphorylation, protein interactions, subcellular distribution, and activity of p21ras GTPase-activating protein.

Authors:  M F Moran; P Polakis; F McCormick; T Pawson; C Ellis
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

5.  Substrate phosphorylation specificity of the human c-kit receptor tyrosine kinase.

Authors:  R Herbst; R Lammers; J Schlessinger; A Ullrich
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

6.  A phosphatidylinositol-3 kinase binds to platelet-derived growth factor receptors through a specific receptor sequence containing phosphotyrosine.

Authors:  J A Escobedo; D R Kaplan; W M Kavanaugh; C W Turck; L T Williams
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

7.  Expression of the ret proto-oncogene in human neuroblastoma cell lines and its increase during neuronal differentiation induced by retinoic acid.

Authors:  T Tahira; Y Ishizaka; F Itoh; M Nakayasu; T Sugimura; M Nagao
Journal:  Oncogene       Date:  1991-12       Impact factor: 9.867

Review 8.  Growth factors and cancer.

Authors:  S A Aaronson
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

9.  The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand.

Authors:  F Lonardo; E Di Marco; C R King; J H Pierce; O Segatto; S A Aaronson; P P Di Fiore
Journal:  New Biol       Date:  1990-11

10.  Identification and biochemical characterization of novel putative substrates for the epidermal growth factor receptor kinase.

Authors:  F Fazioli; D P Bottaro; L Minichiello; A Auricchio; W T Wong; O Segatto; P P Di Fiore
Journal:  J Biol Chem       Date:  1992-03-15       Impact factor: 5.157

View more
  20 in total

Review 1.  Neurotrophic factors and their receptors in axonal regeneration and functional recovery after peripheral nerve injury.

Authors:  J Gordon Boyd; Tessa Gordon
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

2.  Molecular heterogeneity of RET loss of function in Hirschsprung's disease.

Authors:  F Carlomagno; G De Vita; M T Berlingieri; V de Franciscis; R M Melillo; V Colantuoni; M H Kraus; P P Di Fiore; A Fusco; M Santoro
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

3.  Shc and Enigma are both required for mitogenic signaling by Ret/ptc2.

Authors:  K Durick; G N Gill; S S Taylor
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

4.  Mitogenic signals and transforming potential of Nyk, a newly identified neural cell adhesion molecule-related receptor tyrosine kinase.

Authors:  L Ling; H J Kung
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

5.  Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade.

Authors:  R M Melillo; M Santoro; S H Ong; M Billaud; A Fusco; Y R Hadari; J Schlessinger; I Lax
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

6.  The sensitivity of activated Cys Ret mutants to glial cell line-derived neurotrophic factor is mandatory to rescue neuroectodermic cells from apoptosis.

Authors:  B Mograbi; R Bocciardi; I Bourget; T Juhel; D Farahi-Far; G Romeo; I Ceccherini; B Rossi
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

7.  Anti-tumor activity of motesanib in a medullary thyroid cancer model.

Authors:  A Coxon; J Bready; S Kaufman; J Estrada; T Osgood; J Canon; L Wang; R Radinsky; R Kendall; P Hughes; A Polverino
Journal:  J Endocrinol Invest       Date:  2011-03-21       Impact factor: 4.256

8.  Central role of the threonine residue within the p+1 loop of receptor tyrosine kinase in STAT3 constitutive phosphorylation in metastatic cancer cells.

Authors:  Zheng-Long Yuan; Ying-Jie Guan; Lijuan Wang; Wenyi Wei; Agnes B Kane; Y Eugene Chin
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

9.  The neuron-specific Rai (ShcC) adaptor protein inhibits apoptosis by coupling Ret to the phosphatidylinositol 3-kinase/Akt signaling pathway.

Authors:  Giuliana Pelicci; Flavia Troglio; Alessandra Bodini; Rosa Marina Melillo; Valentina Pettirossi; Laura Coda; Antonio De Giuseppe; Massimo Santoro; Pier Giuseppe Pelicci
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

10.  Differential activation of the Ras/extracellular-signal-regulated protein kinase pathway is responsible for the biological consequences induced by the Axl receptor tyrosine kinase.

Authors:  Y W Fridell; Y Jin; L A Quilliam; A Burchert; P McCloskey; G Spizz; B Varnum; C Der; E T Liu
Journal:  Mol Cell Biol       Date:  1996-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.